Jefferies lowered estimates and its price target on Impax Laboratories (NASDAQ: IPXL) from $21.00 to $20.00 citing AXR competition.

This article: 144 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE